X

Xenon Pharmaceuticals

Clinical-stage neurological disorder therapeutics developer

Director/Senior Director - Corporate Communications

PR & CommunicationsConfirmed live in the last 24 hours
Full-timeBoston, MA, USA

About the Job

Requirements

  • A bachelor's degree or equivalent is required, ideally with a specialization in Life Sciences, Communications, or Liberal Arts; a master's or advanced degree is preferred.
  • Biotech or pharmaceutical industry experience is required, along with 10 or more years of communications experience, ideally in healthcare.
  • Expertise in written, verbal, and presentation communications, including the ability to translate complex scientific information and clinical data for healthcare professional and patient audiences.
  • A proven track record of developing corporate, product, and brand communication messaging and materials.
  • Experience developing executive-level communications and engaging directly with senior management.
  • Comprehensive understanding of the biotech industry, drug development, and commercialization.
  • Issues-management experience, including planning for and publicly addressing high-profile business topics with key external stakeholders.
  • Ability to build in-depth knowledge of a company, its business strategies, and objectives, develop innovative concepts, and communicate and promote ideas to gain organizational support.
  • Ability to assess abstract ideas, variables, and assumptions across functional areas and identify strategies and solutions.
  • Ability to build trusted relationships and influence without authority, interact with executive-level management and diverse functions, and navigate critical matters.
  • Ability to work with functions, teams, individual contributors, contractors, agency partners, and vendors to gain consensus, develop strategies, or execute programs.

Responsibilities

  • Develop and execute communications strategies to promote and protect the company’s reputation, build awareness of Xenon and its emerging commercial product portfolio, and support corporate news including business updates, clinical trial milestones, data readouts, and future product launches.
  • Align external and internal communications and help ensure teams uphold the company’s culture and shared values.
  • Work with the Senior Vice President of Corporate Affairs and the broader Corporate Affairs team, corporate, commercial, medical, and senior leaders to execute corporate and product communications strategy and develop messaging about clinical, regulatory, and commercial progress for investors, media, healthcare professionals, and patients.
  • Work with the Corporate Communications team, Executive Leadership Team, Patient Advocacy, Clinical Development, Medical Affairs, Commercial, Legal, and Regulatory to maintain an in-depth understanding of corporate and brand strategies, commercial performance, and pipeline progress.
  • Increase awareness of Xenon’s leadership in epilepsy, its potential azetukalner launch for focal seizures, and its transition to a fully integrated commercial organization.
  • Collaborate with Corporate Affairs, the Executive Leadership team, and Commercial and Medical Affairs leaders to develop consistent messaging and execute communications strategies related to company strategy, the late-stage and future commercial product portfolio, and regulatory, commercial, and data milestones for azetukalner.
  • Contribute late-stage pipeline content to quarterly earnings announcements, including press releases, scripts, questions and answers, regulatory filings, and corporate presentations, in collaboration with executive leaders and Corporate Affairs.
  • Support investor-focused pipeline, financial, and corporate strategy communications, including preparing messaging for banking conferences and other investor events.
  • Lead or support development of corporate and investor presentations.
  • Maintain the investor website with current pipeline, event, and investor-material information.
  • Develop corporate and late-stage product messaging and materials, including press releases, questions and answers, executive talking points, and social media content, in collaboration with relevant company functions.
  • Partner with Commercial and Medical Affairs on cross-functional launch planning for azetukalner in focal seizures.
  • Work with the website and communications agency partner to develop and execute content strategy for Xenon’s corporate website and social channels, supporting awareness of azetukalner, unmet needs and treatment gaps, and the company’s commitment to healthcare professionals and patients.
  • Develop and execute communications strategy for priority medical congresses, including AAN and AES.
  • Work with Competitive Intelligence and company leaders to monitor competitors’ performance and messaging, as well as industry, regulatory, and other relevant trends, and use findings to inform differentiated product messaging.
  • Support investigator communications for ongoing late-stage clinical trials in collaboration with Clinical Operations and Medical Affairs.
  • Partner with Corporate Affairs and Legal to ensure external communications are accurate and consistent with corporate messaging, and manage review of external corporate and product materials.
  • Plan and manage budget proposals and approved budgets in accordance with company strategic and operating plans and Finance policies.
  • Act in accordance with company policies, including the Code of Business Conduct and Ethics, and ensure policies are understood and followed by direct reports, if any.
  • Travel up to 15% as required.
  • Perform other duties as required.

Desired Qualifications

  • Significant expertise in U.S. brand launches and business strategies.
  • Healthcare-sector communications experience.
  • A master's or advanced degree.

About the Company

Xenon Pharmaceuticals

Clinical-stage neurological disorder therapeutics developer

Xenon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapies for neurological disorders, especially epilepsy, through research and collaboration with partners and licensors to support eventual product commercialization. Its drug candidates are designed to treat CNS and genetic contributors to disease, with examples like XEN007 reaching Phase 2 proof-of-concept in treatment-resistant pediatric childhood absence epilepsy, illustrating targeted therapeutic development. The company concentrates on genetics-informed neurology and maintains a pipeline funded in part by partnerships and licensing, setting it apart from broader pharma players. Its goal is to discover, develop, and bring therapies to patients to address unmet needs in neurology and epilepsy.

Company size
201-500
Company stage
IPO
Headquarters
Burnaby, Canada
Founded
1996

Recently Posted Jobs

Explore more opportunities at Xenon Pharmaceuticals

See more jobs